Table 3.
Proportion of people with major cardiovascular risk factors amongst all those with type 2 diabetes (N = 60,327) and those prescribed an SGLT2 inhibitor (N = 1642)
| Cardiovascular risk factor | RCGP RSC total T2DM group (N = 60,327) | RCGP RSC SGLT2 user group (N = 1642) | ||
|---|---|---|---|---|
| Risk factor present n (%*) | 95% confidence intervals %* | Risk factor present n (%*) | 95% confidence intervals %* | |
| Myocardial infarction | 2978 (4.9) | 4.8–5.1 | 65 (4.0) | 3.2–4.8 |
| Coronary artery disease | 3542 (5.9) | 5.7–6.0 | 78 (4.8) | 3.9–5.6 |
| Unstable angina | 528 (0.9) | 0.8–0.9 | 22 (1.3) | 0.9–1.8 |
| Stroke | 2607 (4.3) | 4.2–4.5 | 44 (2.7) | 2.1–3.3 |
| Peripheral artery disease | 2679 (4.4) | 4.3–4.6 | 56 (3.4) | 2.7–4.1 |
| Any major cardiovascular risk factor | 9481 (15.7) | 15.5–16.0 | 182 (11.1) | 9.8–12.4 |
* Percentage of people within group